Danish medical cannabis hiccups following CannTrust Scandal
Denmark’s ambitious medical cannabis program is being stymied by the CannTrust scandal and price issues as new figures show patient numbers flat-lining. Canadian firm CannTrust has been hounded by the authorities and the markets after an ‘illegal growing operation’ was discovered in one of its domestic cultivation facilities. Shortly after this discovery it emerged that CannTrust’s partner in Denmark, StenoCare, had sold some of these illegal buds to its patients – and CannTrust has since ceased the sale and shipment of all cannabis products. The impact of this in the Danish market will be most readily felt in the third quarter, whilst the Marijuana Business Daily website reports that price issues have had an impact on the success of the programme, to date. ‘Sluggish Growth’ Figures from the Danish Health Authority show that in the second quarter, 1,844 cannabis prescriptions were redeemed by 1,045 patients, compared to 1,765 prescriptions for 1,007 patients in quarter one. Rikke Jakobsen, CEO of Cannabis Denmark, a nongovernmental organization said he believed ‘pricing and a the lack of competition’ for the sluggish growth. He told Marijuana Business Daily: “We saw the explosive increase in prescriptions when the oil from CannTrust was introduced on the Danish…
Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Danish medical cannabis hiccups following CannTrust Scandal
reposted by Cannabis News World
You must log in to post a comment.